An unstoppable force that’s minting millionaires …

Image

I hate cannabis; I wouldn’t touch it with a ten-foot pole. But I love the medical miracles it’s creating.

And whether you hate it or love it, there’s no denying its unstoppable march to legalization.

Cannabis first became legal in two states in 2012. Today, just seven years later, 33 states have legalized cannabis for medical use.

Now in 2019 and 2020, even more legislative efforts and ballot initiatives are about to do the same:

Image

Connecticut Gov. Ned Lamont says, “The time has come for Connecticut to responsibly legalize marijuana.”

Illinois Gov. J.B. Pritzker says, “The path forward in Illinois is clear. We need to legalize marijuana.”

And New York Gov. Andrew Cuomo is even more blunt: “New York has to establish a regulated adult-use cannabis program.”

Also speaking out in support of legalization are the governors of Minnesota, New Mexico, Rhode Island, Kansas and Wisconsin.

Looking ahead to the 2020 elections, states like Arizona, Florida, Ohio and North Dakota will likely consider ballot measures to fully legalize marijuana; while Mississippi, Nebraska and South Dakota could see medical cannabis questions go before voters.

Even in conservative Texas, Gov. Greg Abbott says he’s open to cannabis decriminalization — something the state Republican Party officially endorsed this year.

Money and Jobs: A Politician’s Dream

It’s easy to see why so many politicians are changing course and supporting legalization.

Not only do their constituents support it overwhelmingly, but it also drives huge revenues into cash-strapped governments.

Colorado, for example, has collected about $815 million in tax revenue from cannabis. About $21 million of that money went to law enforcement. Another $200 million went to schools.

In Pueblo, Colo., the government gave away more than $500,000 in college scholarships in 2018 to deserving students — all from cannabis tax revenue.

And then there’s jobs.

Every politician campaigns on the promise of bringing jobs to their constituents. They now know they can simply look to the cannabis industry to fulfil that pledge.

Nationwide, 64,000 cannabis jobs were added in 2018 alone. That’s a lot more than ALL the workers who currently toil in the entire coal mining industry.

In fact, the growth in cannabis jobs is outpacing the growth in every other industry in the country.

All told, more than 211,000 people are supporting their families thanks to cannabis jobs in the U.S.

But this is just the beginning. Within a few years, more than a million are projected to work in cannabis. More people will be making cannabis products than making cars.

Big Profits

As legalization of cannabis spreads, it can cause massive disruption in major American industries. And it can cause rapid price surges in cannabis stocks.

In 2018, when legalization took effect in Canada, a leading cannabis grower, Canopy Growth, rose by 100%; Cronos Group, a medical cannabis producer, jumped 121%; and Tilray, a cannabis research and tech company, soared 398%.

We saw the same thing happen in the U.S. when legalization ballot initiatives passed in eight states. GW Pharmaceuticals went up 228%, KushCo Holdings jumped 252%, and Corbus Pharmaceuticals skyrocketed 668%.

The big questions now are:

What’s the best way to select the most profitable cannabis stocks, while avoiding the riskiest?

How do you do it consistently — not just to grab a winning trade here and there, but to grow a portfolio of cannabis stocks rapidly and steadily over time?

Then, how do you cash out as you go — so you can actually enjoy and use the profits month after month?

Stand by — answers coming soon.

Best,

Martin

About the Weiss Ratings Founder

Dr. Weiss is the founder of Weiss Ratings, the nation’s leading provider of 100% independent grades on stocks, mutual funds and financial institutions, as well as the world’s only ratings agency that grades cryptocurrencies. He founded his company in 1971, and thanks largely to his strict independence, has established a 50-year record of accuracy. Forbes called him “Mr. Independence.” The U.S. Government Accountability Office (GAO) reported that his insurance company ratings outperformed those of A.M. Best, S&P and Moody’s by at least three to one. And The Wall Street Journal reported that investors using the Weiss stock ratings could have made more money than those following the grades issued by Merrill Lynch, J.P. Morgan, Goldman Sachs, Standard & Poor’s and every other firm reviewed.

Top Tech Stocks
See All »
B
MSFT NASDAQ $404.27
B
AAPL NASDAQ $167.04
B
NVDA NASDAQ $795.18
Top Consumer Staple Stocks
See All »
B
WMT NYSE $60.14
Top Financial Stocks
See All »
B
B
BRKA NYSE $617,283.99
B
V NYSE $271.37
Top Energy Stocks
See All »
B
B
CVX NYSE $161.92
B
COP NYSE $127.81
Top Health Care Stocks
See All »
B
AMGN NASDAQ $262.75
B
SYK NYSE $327.68
Top Real Estate Stocks
See All »
Weiss Ratings